Targeted LSAM-Cisplatin Infusion in Gliomas, Evaluation of Response

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
Open-label, dose-escalating, Phase 1/2a trial of Large Surface Area Microparticle (LSAM)-Cisplatin to treat participants with diffuse midline glioma (DMG), including diffuse intrinsic pontine glioma (DIPG), via stereotactic infusion under intraoperative magnetic resonance imaging (MRI) guidance.
Epistemonikos ID: 1f6c77c2910ab5af935cb7f58cc77a8386468d9b
First added on: Aug 17, 2026